Shield Therapeutics plc (STX) — Cash Flow Quality Index

Latest as of June 2020: 0.77x

Shield Therapeutics plc (STX) has a Cash Flow Quality Index of 0.77x as of June 2020. Operating cash flow of GBX2.40 Million is below net income of GBX3.12 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore STX cash flow metrics to assess how effectively this company generates cash.

Cash Flow Quality Index

0.77x

Operating CF / Net Income

Operating Cash Flow

GBX2.40 Million

GBX

Net Income

GBX3.12 Million

GBX

Data as of

Jun 2020

Most recent filing

Annual Cash Flow Quality Index for Shield Therapeutics plc (None–None)

Year-by-year earnings quality comparison for Shield Therapeutics plc. For live market cap and the full company financial profile, see Shield Therapeutics plc (STX) total market value.

Year	Quality Index	Operating CF (GBX)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.